JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
10x Genomics
TXG
$12.2B
| $4.26M | ﹤0.01% |
296,902
-58,586
| -16% | -$925K |
2019 Q3
21 quarters
|
|
3377
Acco Brands
ACCO
$397M
| $4.26M | ﹤0.01% |
811,629
+293,506
| +57% | +$1.63M |
2013 Q2
46 quarters
|
|
|
MRSH
3378
PUT
Marsh
MRSH
$81.2B
| $4.25M | ﹤0.01% |
+20,000
| New | +$4.44M |
2024 Q4
0 quarters
|
|
3379
Cimpress
CMPR
$1.83B
| $4.25M | ﹤0.01% |
59,209
+37,272
| +170% | +$2.92M |
2017 Q4
28 quarters
|
|
3380
CALL
Devon Energy
DVN
$52.4B
| $4.25M | ﹤0.01% |
129,700
-55,600
| -30% | -$2.09M |
2021 Q4
12 quarters
|
|
3381
Ubiquiti
UI
$37.6B
| $4.25M | ﹤0.01% |
12,789
-17,024
| -57% | -$5.13M |
2013 Q2
46 quarters
|
|
3382
PUT
Alcon
ALC
$30.8B
| $4.24M | ﹤0.01% |
50,000
| – | – |
2024 Q2
2 quarters
|
|
|
UHT
3383
Universal Health Realty Income Trust
UHT
$509M
| $4.24M | ﹤0.01% |
113,962
+32,128
| +39% | +$1.31M |
2013 Q2
46 quarters
|
|
3384
Lifestance Health
LFST
$4.5B
| $4.24M | ﹤0.01% |
575,154
+480,518
| +508% | +$3.45M |
2021 Q2
14 quarters
|
|
3385
CareDx
CDNA
$3.47B
| $4.24M | ﹤0.01% |
197,912
+173,776
| +720% | +$4.23M |
2017 Q4
28 quarters
|
|
3386
Zai Lab
ZLAB
$2.73B
| $4.23M | ﹤0.01% |
161,635
+23,510
| +17% | +$653K |
2020 Q1
19 quarters
|
|
3387
Winmark
WINA
$1.07B
| $4.22M | ﹤0.01% |
10,747
+2,025
| +23% | +$796K |
2017 Q3
29 quarters
|
|
3388
DHT Holdings
DHT
$3.82B
| $4.22M | ﹤0.01% |
454,647
+123,599
| +37% | +$1.27M |
2016 Q4
32 quarters
|
|
3389
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11B
| $4.22M | ﹤0.01% |
117,774
-27,729
| -19% | -$1.04M |
2022 Q4
8 quarters
|
|
|
TIXT
3390
DELISTED
TELUS International
TIXT
| $4.22M | ﹤0.01% |
1,076,096
-5,118,918
| -83% | -$19.4M |
2024 Q3
1 quarter
|
|
3391
ARKO Corp
ARKO
$468M
| $4.21M | ﹤0.01% |
639,070
+399,387
| +167% | +$2.75M |
2020 Q1
19 quarters
|
|
3392
America's Car Mart
CRMT
$8.76M
| $4.21M | ﹤0.01% |
82,156
+8,555
| +12% | +$390K |
2017 Q4
28 quarters
|
|
|
LGF.B
3393
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $4.21M | ﹤0.01% |
557,053
+277,960
| +100% | +$1.95M |
2016 Q4
32 quarters
|
|
|
RC
3394
Ready Capital
RC
$187M
| $4.2M | ﹤0.01% |
615,431
+278,658
| +83% | +$2M |
2016 Q1
35 quarters
|
|
3395
PUT
The GEO Group
GEO
$4.13B
| $4.2M | ﹤0.01% |
150,000
| – | – |
2024 Q3
1 quarter
|
|
|
SCHQ
3396
Schwab Long-Term US Treasury ETF
SCHQ
$882M
| $4.19M | ﹤0.01% |
133,375
-140,182
| -51% | -$4.62M |
2023 Q3
5 quarters
|
|
3397
Artisan Partners
APAM
$2.48B
| $4.19M | ﹤0.01% |
97,371
-4,051
| -4% | -$185K |
2017 Q1
31 quarters
|
|
3398
Fidelity Low Volatility Factor ETF
FDLO
$1.4B
| $4.18M | ﹤0.01% |
69,054
-3,757
| -5% | -$232K |
2023 Q1
7 quarters
|
|
|
CFB
3399
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $4.17M | ﹤0.01% |
275,517
+178,658
| +184% | +$2.96M |
2019 Q3
21 quarters
|
|
|
NFBK
3400
DELISTED
Northfield Bancorp
NFBK
| $4.17M | ﹤0.01% |
358,962
+78,843
| +28% | +$981K |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.